Functional mitral regurgitation: structural modifications with percutaneous valve repair with MitraClip.

MitraClip functional mitral regurgitation (MR) mitral repair percutaneous

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 21 9 2020
pubmed: 22 9 2020
medline: 22 9 2020
Statut: ppublish

Résumé

Mitral regurgitation (MR) is one of the most prevalent valvular diseases in our society. Transcatheter mitral valve repair (TMVR) with the MitraClip A single-centre, prospective and observational study including consecutive patients admitted between October 2015 and October 2019 for TMVR was designed. The mitral valve annulus (MVA) was analyzed using the three-dimensional MVQ QLAB mitral valve quantification software (Philips; Amsterdam, The Netherlands). Clinical data was collected retrospectively. Eighty-two MitraClip MitraClip

Sections du résumé

BACKGROUND BACKGROUND
Mitral regurgitation (MR) is one of the most prevalent valvular diseases in our society. Transcatheter mitral valve repair (TMVR) with the MitraClip
METHODS METHODS
A single-centre, prospective and observational study including consecutive patients admitted between October 2015 and October 2019 for TMVR was designed. The mitral valve annulus (MVA) was analyzed using the three-dimensional MVQ QLAB mitral valve quantification software (Philips; Amsterdam, The Netherlands). Clinical data was collected retrospectively.
RESULTS RESULTS
Eighty-two MitraClip
CONCLUSIONS CONCLUSIONS
MitraClip

Identifiants

pubmed: 32953758
doi: 10.21037/atm.2020.03.45
pii: atm-08-15-958
pmc: PMC7475407
doi:

Types de publication

Journal Article

Langues

eng

Pagination

958

Informations de copyright

2020 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.03.45). The series “Structural Heart Disease: The Revolution” was commissioned by the editorial office without any funding or sponsorship. DHV served as the unpaid Guest Editor of the series and serves as an unpaid editorial board member of Annals of Translational Medicine from Aug 2019 to Jul 2021. The authors have no other conflicts of interest to declare.

Références

J Interv Cardiol. 2014 Oct;27(5):516-24
pubmed: 25203054
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
N Engl J Med. 2018 Dec 13;379(24):2307-2318
pubmed: 30280640
Circ Cardiovasc Interv. 2014 Jun;7(3):390-9
pubmed: 24895448
Eur Heart J. 2016 Feb 21;37(8):703-12
pubmed: 26614824
J Am Coll Cardiol. 2013 Sep 17;62(12):1052-1061
pubmed: 23747789
N Engl J Med. 2011 Apr 14;364(15):1395-406
pubmed: 21463154
Echocardiography. 2019 Apr;36(4):732-741
pubmed: 30801804
J Am Coll Cardiol. 2009 Aug 18;54(8):686-94
pubmed: 19679246
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
Eur Heart J Cardiovasc Imaging. 2014 Apr;15(4):353-65
pubmed: 24554131
Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):643-651
pubmed: 31732437
J Echocardiogr. 2019 Jun;17(2):84-94
pubmed: 30291509
Eur Heart J. 2003 Jul;24(13):1231-43
pubmed: 12831818
Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1020-1025
pubmed: 27212447
J Thorac Cardiovasc Surg. 2001 Oct;122(4):674-81
pubmed: 11581597
J Am Coll Cardiol. 2015 Jul 21;66(3):308-321
pubmed: 26184623
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442

Auteurs

Alberto Alperi (A)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.

Pablo Avanzas (P)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Departamento de Medicina, University of Oviedo, Oviedo, Spain.

Isaac Pascual (I)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Functional Biology Department, University of Oviedo, Oviedo, Spain.

Antonio Adeba (A)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Rebeca Lorca (R)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Victor León (V)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Marcel Almendarez (M)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Hector Cubero-Gallego (H)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Iria Silva-Conde (I)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.

César Moris (C)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Departamento de Medicina, University of Oviedo, Oviedo, Spain.

Daniel Hernandez-Vaquero (D)

Heart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Functional Biology Department, University of Oviedo, Oviedo, Spain.

Classifications MeSH